Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adm Tronics Unlimited Inc (OP:ADMT)

0.0900 UNCHANGED
Streaming Delayed Price Updated: 9:43 AM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0900
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0900
Today's Range 0.0900 - 0.0900
52wk Range 0.0477 - 0.0990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ADM Tronics Reports First Quarter of Fiscal Year 2026 Results
Via ACCESS Newswire
ADM Tronics Reports Fiscal Year 2025
Via ACCESS Newswire

Performance

YTD
+11.5%
+11.5%
1 Month
-8.2%
-8.2%
3 Month
+65.1%
+65.1%
6 Month
+29.1%
+29.1%
1 Year
+17.3%
+17.3%

More News

Read More
ADM Tronics Reports Second Quarter of Fiscal Year 2025 Results
Via ACCESSWIRE
ADM Tronics Reports First Quarter of Fiscal Year 2025 Results
Via ACCESSWIRE
ADM Tronics Reports Fiscal Year 2024
Via ACCESSWIRE
ADM Tronics Shareholder Video Conference Replay Available Now for Viewing Online with Update on Vet-Sonotron Veterinary Pain Treatment Technology
Via ACCESSWIRE
ADM Tronics Reports First Quarter of Fiscal Year 2024 Results
Via ACCESSWIRE
ADM Tronics Reports Fiscal Year 2023
Via ACCESSWIRE
ADM Tronics Reports Third Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
ADM Tronics to Host Shareholder Video Call on March 27 to Update Launch and Significance of Vet-Sonotron Veterinary Pain Treatment Device
Via ACCESSWIRE
ADM Tronics CEO Presents Vet-Sonotron Veterinary Therapy Device at Medical Device Industry Webinar
Via ACCESSWIRE
ADM Tronics’ Vet-Sonotron(R) Veterinary Pain Treatment Device Now in Production and Already Receiving Pre-Orders
Via ACCESSWIRE
Novel Therapeutic Technology Developed & Manufactured by ADM Tronics for Origin Life Sciences to Begin Clinical Study on Onychomycosis
Via ACCESSWIRE
ADM Tronics Prepares for Commercial Launch of Vet-Sonotron(R) Veterinary Therapy Device
Via ACCESSWIRE
ADM Tronics Reports First Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
ADM Tronics Prepares for Launch of Vet-Sonotron(R) Novel Pain Treatment for Veterinary Market
Via ACCESSWIRE
ADM Tronics Issues Shareholder Update Letter
Via ACCESSWIRE
ADM Tronics Reports Second Quarter of Fiscal Year 2023 Results
Via ACCESSWIRE
ADM Tronics Reports Fiscal Year 2022
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Economy
Aveta.Life Collaborates with ADM Tronics for Regulatory Development
Via NewMediaWire
ADM Tronics Reports Third Quarter of Fiscal Year 2022 Results
From ADM Tronics Unlimited, Inc.
Via AccessWire
Research Study Proves Calmer Canine Veterinary Therapy Device Resolves Separation Anxiety in Dogs
Via NewMediaWire
ADM Tronics Reports Second Quarter of Fiscal Year 2022 Results
From ADM Tronics Unlimited, Inc.
Via AccessWire
Topics Regulatory Compliance
ADM Tronics Signs Agreement for Marketing of Vet-Sonotron Veterinary Therapy Device
Via NewMediaWire
Topics Regulatory Compliance
ADM Tronics Releases Pre-Production Evaluation Units of New Vet-Sonotron Therapy Device for Veterinary Market
Via NewMediaWire
Topics Regulatory Compliance

Frequently Asked Questions

Is Adm Tronics Unlimited Inc publicly traded?
Yes, Adm Tronics Unlimited Inc is publicly traded.
What exchange does Adm Tronics Unlimited Inc trade on?
Adm Tronics Unlimited Inc trades on the OTC Traded
What is the ticker symbol for Adm Tronics Unlimited Inc?
The ticker symbol for Adm Tronics Unlimited Inc is ADMT on the OTC Traded
What is the current price of Adm Tronics Unlimited Inc?
The current price of Adm Tronics Unlimited Inc is 0.0900
When was Adm Tronics Unlimited Inc last traded?
The last trade of Adm Tronics Unlimited Inc was at 10/17/25 09:43 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.